versija spausdinimui
(0)
KEY STOCKS FOR THE WEEK 26/06—29/06
Sanitas, Lithuanian based manufacturer of pharmaceuticals, is expected to see its share price suffering at least a small correction this week after spectacular performance last week. While mid term fundamentals remain inspiring after the 5-month results announcement last week, we anticipate strong selling pressure due to short term investor profiteering. Sanitas’ mother company Invalda is expected to follow suite.
Vilniaus Baldai, Lithuanian manufacturer of furniture, has released it 5-month result on Friday, with an EBITDA, figure of LTL 5.9M. We estimate that the forward EV/EBITDA for the company currently stands at ~9.6, making it a comparatively cheap buy.
LAST WEEK IN THE BALTIC STOCK MARKETS: MARKETS START TO SHOW PROMISE AGAIN... AS INDICES START THEIR
CLIMB FOR 52W HIGHS
Sanitas, Lithuanian based manufacturer of pharmaceuticals, has announced its 5-month EBITDA of LTL 46.2M, quite beyond our positive expectations. While it would be hard to attribute all of +34.3% boost in share price during the week to the results factor alone (even when combined with a healthy consolidated net profit of LTL 15.5M), it has undoubtedly served as strong reassuring sign to investors, which was also reflected in record high turnover of the stock.
Meanwhile, Sanitas’ parent company, Lithuania’s investment conglomerate Invalda, had its share price display close to exact proportion of theoretical price appreciation of +12.9% (Invalda owns 30.71% of Sanitas shares).
Ukio Bankas has announced of entering the venture capital business through establishment of daughter company “Ukio banko rizikos kapitalo valdymas”. During the week of the news, share price increased by 6.9%.
City Service, Lithuanian leader in facility management services, has announced to start offering energetic certification services (a certificate will be obligatory for all buildings in Lithuania from 1st of January 2009 ). Investors reacted positively to the news, with share price appreciating by +3.6%.
Sanitas, Lithuanian based manufacturer of pharmaceuticals, is expected to see its share price suffering at least a small correction this week after spectacular performance last week. While mid term fundamentals remain inspiring after the 5-month results announcement last week, we anticipate strong selling pressure due to short term investor profiteering. Sanitas’ mother company Invalda is expected to follow suite.
Vilniaus Baldai, Lithuanian manufacturer of furniture, has released it 5-month result on Friday, with an EBITDA, figure of LTL 5.9M. We estimate that the forward EV/EBITDA for the company currently stands at ~9.6, making it a comparatively cheap buy.
LAST WEEK IN THE BALTIC STOCK MARKETS: MARKETS START TO SHOW PROMISE AGAIN... AS INDICES START THEIR
CLIMB FOR 52W HIGHS
Sanitas, Lithuanian based manufacturer of pharmaceuticals, has announced its 5-month EBITDA of LTL 46.2M, quite beyond our positive expectations. While it would be hard to attribute all of +34.3% boost in share price during the week to the results factor alone (even when combined with a healthy consolidated net profit of LTL 15.5M), it has undoubtedly served as strong reassuring sign to investors, which was also reflected in record high turnover of the stock.
Meanwhile, Sanitas’ parent company, Lithuania’s investment conglomerate Invalda, had its share price display close to exact proportion of theoretical price appreciation of +12.9% (Invalda owns 30.71% of Sanitas shares).
Ukio Bankas has announced of entering the venture capital business through establishment of daughter company “Ukio banko rizikos kapitalo valdymas”. During the week of the news, share price increased by 6.9%.
City Service, Lithuanian leader in facility management services, has announced to start offering energetic certification services (a certificate will be obligatory for all buildings in Lithuania from 1st of January 2009 ). Investors reacted positively to the news, with share price appreciating by +3.6%.
